Cargando…

Recent advances in neoantigen vaccines for treating non‐small cell lung cancer

The breakthrough of programmed cell death protein 1 (PD‐1) blockade therapy has changed the clinical treatment of non‐small cell lung cancer (NSCLC) in the past few years. The success of PD‐1 blockade therapy has been attributed to high tumor mutation burden and high immunogenicity of lung cancer ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Shu, Chen, Fungjun, Xu, Mingyuan, Liu, Baorui, Wang, Lifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2023
Materias:	Mini Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693939/ https://www.ncbi.nlm.nih.gov/pubmed/37905603 http://dx.doi.org/10.1111/1759-7714.15126

Ejemplares similares

Personalized neoantigen vaccination with synthetic long peptides: recent advances and future perspectives
por: Chen, Xiaotong, et al.
Publicado: (2020)

Personalized cancer neoantigen vaccines come of age
por: Chu, Yanhong, et al.
Publicado: (2018)

Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer
por: Ding, Zhenyu, et al.
Publicado: (2021)

Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises
por: Ashi, Mohamad Omar, et al.
Publicado: (2022)

Recent advances in vaccine and immunotherapy for COVID-19
por: Rabaan, Ali A., et al.
Publicado: (2020)

Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens
por: Pan, Ren-You, et al.
Publicado: (2018)

Recent advances and safety issues of transgenic plant-derived vaccines
por: Guan, Zheng-jun, et al.
Publicado: (2013)

Recent Advances in Cancer Immunotherapy with a Focus on FDA-Approved Vaccines and Neoantigen-Based Vaccines
por: Hargrave, Anna, et al.
Publicado: (2023)

Computational cancer neoantigen prediction: current status and recent advances
por: Fotakis, G., et al.
Publicado: (2021)

Role of long non‐coding RNA in drug resistance in non‐small cell lung cancer
por: Wang, Leirong, et al.
Publicado: (2018)

Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer
por: Liang, Hongge, et al.
Publicado: (2022)

Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2
por: Bilal, Muhammad, et al.
Publicado: (2020)

Temporary hemodialysis catheters: recent advances
por: Clark, Edward G, et al.
Publicado: (2014)

Recent Advances in Toxoplasma gondii Immunotherapeutics
por: Lim, Sherene Swee-Yin, et al.
Publicado: (2014)

Recent advances in rational approaches for enzyme engineering
por: Steiner, Kerstin, et al.
Publicado: (2012)

Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancer
por: Conibear, John
Publicado: (2020)

Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
por: Blass, Eryn, et al.
Publicado: (2021)

Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations
por: Li, Fenge, et al.
Publicado: (2021)

Epidermal Growth Factor Receptor-Targeted Neoantigen Peptide Vaccination for the Treatment of Non-Small Cell Lung Cancer and Glioblastoma
por: Li, Fenge, et al.
Publicado: (2023)

KRAS oncogene may be another target conquered in non‐small cell lung cancer (NSCLC)
por: Chen, Hanxiao, et al.
Publicado: (2020)

Minireview: Recent Advances in Extranuclear Steroid Receptor Actions
por: Hammes, Stephen R., et al.
Publicado: (2011)

Recent advances of Cas12a applications in bacteria
por: Meliawati, Meliawati, et al.
Publicado: (2021)

Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
por: Zhang, Rui, et al.
Publicado: (2019)

Oncogene addiction and tumor mutational burden in non‐small‐cell lung cancer: Clinical significance and limitations
por: Smolle, Elisabeth, et al.
Publicado: (2019)

Ileocaecal endometriosis, a marker of advanced disease: to treat or not to treat?
por: Mijatovic, V
Publicado: (2019)

Immunotherapy in Cancer Management: A Literature Review of Clinical Efficacy of Pembrolizumab in the Non-small Cell Lung Cancer Treatment
por: Miquelotti, Luísa Biscaglia, et al.
Publicado: (2023)

Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC)
por: Tan, Aaron C.
Publicado: (2020)

Practical implications to contemplate when considering radical therapy for stage III non-small-cell lung cancer
por: Storey, Claire L., et al.
Publicado: (2020)

Recent advances in technology supporting biopharmaceutical production from mammalian cells
por: Butler, M., et al.
Publicado: (2012)

Personalized Neoantigen-Pulsed DC Vaccines: Advances in Clinical Applications
por: Tang, Lin, et al.
Publicado: (2021)

Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
por: Segura-Collar, Berta, et al.
Publicado: (2023)

Magnetic resonance imaging for N staging in non-small cell lung cancer: A systematic review and meta-analysis
por: Zhang, Yuanyuan, et al.
Publicado: (2015)

ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer
por: Sun, Dantong, et al.
Publicado: (2021)

Recent progress in vaccine development targeting pre-clinical human toxoplasmosis
por: Chu, Ki-Back, et al.
Publicado: (2023)

Recent advances on halohydrin dehalogenases—from enzyme identification to novel biocatalytic applications
por: Schallmey, Anett, et al.
Publicado: (2016)

Navigating the cellular landscape in tissue: Recent advances in defining the pathogenesis of human disease
por: Chen, Helen Y., et al.
Publicado: (2022)

Challenges & Solutions for Recent Advancements in Multi-Drugs Resistance Tuberculosis: A Review
por: Yadav, Pramod
Publicado: (2023)

The role of IL‐6 in immunotherapy of non‐small cell lung cancer (NSCLC) with immune‐related adverse events (irAEs)
por: Ke, Wanhai, et al.
Publicado: (2020)

A Bibliometric Analysis of Triptolide and the Recent Advances in Treating Non–Small Cell Lung Cancer
por: Yang, Quancheng, et al.
Publicado: (2022)

Comparison and discussion of the treatment guidelines for small cell lung cancer
por: Zhao, Honglin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lr5isehleokksrt0t32d4rj6h8